tiprankstipranks
Oric Pharmaceuticals Inc (ORIC)
:ORIC
US Market

Oric Pharmaceuticals (ORIC) Income Statement

Compare
323 Followers

Oric Pharmaceuticals Income Statement

Last quarter (Q4 2024), Oric Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Oric Pharmaceuticals's net income was $-36.31M. See Oric Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -1.03M$ -966.00K$ -897.00K$ -970.00K
Operating Expenses
$ 142.90M$ 110.78M$ 86.77M$ 78.87M$ 49.34M
Depreciation and Amortization
$ 0.00$ 1.03M$ 966.00K$ 897.00K$ 970.00K
EBITDA
$ -142.90M$ -109.75M$ -91.77M$ -77.97M$ -74.19M
Operating Income
$ -142.90M$ -110.78M$ -91.77M$ -78.87M$ -74.19M
Other Income/Expenses
$ 15.05M$ 10.08M$ 2.65M$ 156.00K$ 483.00K
Pretax Income
$ -127.85M$ -100.70M$ -89.12M$ -78.72M$ -73.70M
Net Income
$ -127.85M$ -100.70M$ -91.48M$ -77.68M$ -97.27M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.83$ -1.96$ -2.31$ -2.05$ -4.43
Diluted EPS
$ -1.83$ -1.96$ -2.31$ -2.05$ -4.43
Weighted Average Shares Outstanding
69.73M 51.45M 39.66M 37.95M 21.94M
Weighted Average Shares Outstanding (Diluted)
69.73M 51.45M 39.66M 37.95M 21.94M
Currency in USD

Oric Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis